Scope
This protocol is intended for fresh-frozen or previously fixed tissue cut on a cryostat and mounted on microscope slides. It describes indirect immunofluorescence with an unlabeled primary antibody and a fluorophore-conjugated secondary antibody.
Use a separate workflow for FFPE tissue, free-floating thick sections, whole mounts, cleared tissue, or cyclic multiplex methods. Product-specific antibody instructions take priority when they specify a validated frozen-tissue preparation.
Safety: Cryostats can expose operators to sharp blades, cold injury, aerosols, and unfixed biological material. Follow cryostat decontamination, sharps, biosafety, formaldehyde, methanol, acetone, and waste procedures required by your institution.
Before you start
| Decision | Why it matters | What to document |
|---|---|---|
| Tissue history | Collection delay, perfusion, pre-fixation, freezing rate, embedding, storage, and freeze-thaw exposure can change morphology, antigen accessibility, and background. | Collection time, fixation before freezing, cryoprotectant or OCT use, freezing method, block orientation, storage temperature, and freeze-thaw events. |
| Section thickness | Thickness affects mechanical stability, antibody penetration, optical sectioning, background, and apparent signal density. | Nominal thickness, cryostat temperature, blade condition, compression, chatter, folds, and tears. |
| Slide adhesion | Weak adhesion can cause partial or complete tissue loss during retrieval, incubation, or washing. | Slide type or coating, time before fixation, drying history, section lifting, and any tissue-dependent adhesion problem. |
| Fixation and access route | Formaldehyde, alcohol, and acetone preserve different structures and expose different epitopes. | Antibody validation application, target compartment, structure that must be preserved, and candidate conditions to compare. |
| Baseline fluorescence | Intrinsic tissue fluorescence and fixation-related fluorescence can resemble specific signal and vary by channel. | Unstained section acquired in every planned channel using the same objective and comparable settings. |
| Acquisition plan | Changing exposure, gain, or processing between groups can create an apparent biological difference. | Microscope, objective, channels, exposure, gain, binning, z-step, flat-field method, and processing rules. |
Materials and reagents
| Category | Required | Selection notes |
|---|---|---|
| Tissue and embedding | Frozen tissue block, OCT or validated embedding medium, cryostat | Preserve orientation and keep the block at a stable cutting temperature appropriate for the tissue. |
| Slides | Positively charged or otherwise validated adhesive slides | Use one slide type consistently; highly fatty, mineralized, fragile, or previously fixed tissues may require additional optimization. |
| Wash buffer | PBS or TBS | Use one defined formulation across comparison groups. |
| Fixation route | Fresh 4% formaldehyde, ice-cold methanol, chilled acetone, or another validated route | Do not assume routes are interchangeable. Organic solvents can extract lipids and soluble material. |
| Permeabilization reagent | Validated detergent when intracellular access is required | Detergent may be included in blocking or antibody diluent, but stronger access can damage membranes and fine morphology. |
| Blocking and antibody diluent | Normal serum, BSA, or a validated commercial buffer | Normal serum is commonly matched to the host species of the secondary antibody. Avoid components incompatible with the detection chemistry. |
| Primary antibody | Antibody validated for frozen-tissue immunofluorescence or supported by appropriate local evidence | Record supplier, catalog number, clone, lot, concentration, dilution, and validation application. |
| Secondary antibody | Fluorophore-conjugated, host-specific secondary antibody | Use a secondary reactive to the primary-antibody host; highly cross-adsorbed reagents are preferred for multiplex work. |
| Mounting and handling | Hydrophobic barrier pen if compatible, humidified chamber, fine forceps, nuclear stain as needed, antifade mounting medium | Use enough volume to cover the tissue and prevent drying; confirm that barrier ink is compatible with the fluorophores and detection system. |
Evidence-based starting conditions
The conditions below are practical screening points reported in current manufacturer protocols. They are not universal optima and should be tested against the specific tissue, target, antibody, and preservation requirement.
| Stage | Starting condition | Interpretation |
|---|---|---|
| Fresh-frozen sectioning | Approximately 6–20 µm on a positively charged slide | A broad starting range used in a current CST frozen-tissue protocol. Select thickness from tissue mechanics, penetration, and imaging requirements. |
| Post-section formaldehyde fixation | Fresh 4% formaldehyde for approximately 15 minutes at room temperature | Common morphology-preserving route; usually requires a separate access decision for intracellular targets. |
| Optional cold methanol treatment | 100% methanol for approximately 10 minutes at −20°C or on ice | Fixes and permeabilizes but can extract lipids and alter membrane-rich or soluble structures. |
| Alternative acetone route | Chilled 100% acetone for approximately 10 minutes, only when supported by the antibody and tissue workflow | A commonly described frozen-section route, but morphology and target retention must be checked locally. |
| Blocking | Approximately 60 minutes at room temperature | Evaluate performance using the secondary-only control instead of assuming that longer blocking is always better. |
| Primary antibody | Manufacturer-recommended dilution, commonly overnight at 4°C | Titrate concentration and compare localization, positive control, and negative-control behavior. |
| Secondary antibody | Manufacturer-recommended dilution for approximately 1–2 hours at room temperature, protected from light | Match the primary host species and include a secondary-only section. |
| Washing | Three gentle washes of approximately 5 minutes between major labeling steps | Keep wash composition, duration, volume, and agitation consistent while avoiding direct force on the section. |
Optional retrieval: Antigen retrieval is not automatically required for frozen sections. Use it only when supported by antibody validation or a controlled comparison, because heat or enzymes can increase section loss and alter morphology.
Procedure
- Document the tissue and block. Record collection delay, fixation before freezing, cryoprotection, embedding medium, orientation, freezing method, storage temperature, and freeze-thaw history.
- Equilibrate the block to the cryostat. Allow the block to reach a stable cutting temperature before trimming. Record compression, chatter, cracks, or curling rather than correcting these artifacts only after staining.
- Cut and mount representative sections. Place sections onto validated adhesive slides without stretching or trapping folds. Include adjacent sections for unstained, secondary-only, positive, and negative controls.
- Handle stored slides without condensation. If slides were stored frozen, keep them inside a closed container while they approach the required handling temperature. Open the container only after the external surface has equilibrated enough to reduce condensation on the tissue.
- Inspect adhesion before staining. Use brightfield inspection to identify folds, tears, incomplete transfer, compression, or lifting. Do not spend antibody on a section whose geometry or attachment already prevents interpretation.
- Apply the selected fixation route. Use the preselected formaldehyde, methanol, acetone, or other validated condition. Keep reagent age, temperature, time, and volume consistent across comparison groups.
- Wash gently and keep the tissue covered. From the first aqueous wash onward, do not allow the section to dry. Avoid direct liquid jets and monitor edges for early lifting.
- Provide intracellular access only when needed. Apply a validated detergent condition for intracellular targets when the fixation route has not already permeabilized the tissue. Use retrieval only as a deliberate antibody- and tissue-specific comparison.
- Define the staining area. Apply a compatible hydrophobic barrier after the section perimeter is dry enough for the pen, while keeping the tissue itself hydrated. Confirm that the reagent volume covers the complete section.
- Measure baseline fluorescence. Acquire the unstained section in every planned channel before interpreting antibody signal or selecting a quenching strategy.
- Block and incubate the primary antibody. Use a humidified chamber, prevent local evaporation, and record antibody identity, clone, lot, concentration, dilution, diluent, time, temperature, and volume.
- Wash reproducibly. Use gentle immersion or low-force exchange with the same number, duration, volume, and agitation for every comparable section.
- Incubate the fluorescent secondary antibody. Protect from light, match the primary-antibody host species, and control cross-reactivity when more than one primary host is used.
- Wash, counterstain, and mount. Remove unbound fluorophore, avoid bubbles and excessive coverslip pressure, and keep section geometry intact.
- Acquire controls first. Confirm section presence, baseline fluorescence, secondary background, known-positive signal, channel identity, and exposure below saturation before imaging experimental sections.
Minimum control set
| Control | Primary question answered | What it cannot prove alone |
|---|---|---|
| Unstained section | How much tissue, fixative, pigment, embedding, or treatment-related fluorescence is present in each channel? | Antibody specificity or secondary-antibody background. |
| Secondary-only section | Does the fluorescent secondary antibody or detection chemistry create background without the primary antibody? | That the primary antibody recognizes only the intended target. |
| Known-positive tissue | Can the staining and acquisition workflow detect the expected tissue and subcellular pattern? | Target dependence in the experimental specimen. |
| Biological or genetic negative | Does signal decrease where the target is absent or substantially reduced? | All sources of tissue autofluorescence, bleed-through, or secondary background. |
| Adjacent or serial section | Is the pattern reproducible in neighboring anatomy or supported by an orthogonal stain? | Exact co-localization on the same section. |
| Single-color control | Does one fluorophore appear in another acquisition channel? | Target specificity or nonspecific antibody binding. |
Stop points and storage
- Frozen blocks: store under the validated conditions for the tissue and study. Record storage duration and every thaw or temperature excursion.
- Unfixed frozen slides: a validated laboratory workflow may allow storage at very low temperature, but humidity, condensation, and epitope stability must be controlled.
- After fixation and washing: a short pause in buffer at 4°C may be acceptable for many targets, but labile epitopes should be processed on a validated schedule.
- During primary incubation: overnight incubation at 4°C is a planned step. Maintain full coverage and humidity.
- After mounting: allow the mountant to cure as directed, then store flat at 4°C protected from light and record the interval before imaging.
- Avoid: repeated freeze-thaw cycles, opening a cold slide box in humid room air, allowing aqueous sections to dry, strong wash force, and storing comparison groups for different durations without validation.
Troubleshooting checkpoints
| Observation | First evidence to inspect | Next guide |
|---|---|---|
| Partial or complete section loss | Charged-slide performance, section drying and storage history, tissue composition, retrieval severity, wash force, and edge lifting before staining. | Uneven-staining patterns |
| No or weak target signal | Known-positive tissue, section presence, acquisition channel and exposure, fixation route, access condition, and antibody validation application. | No-signal workflow |
| High diffuse background | Secondary-only section, exposure saturation, antibody titration, wash consistency, tissue drying, and hydrophobic-barrier compatibility. | High-background patterns |
| Strong channel-wide fluorescence | Unstained tissue in every channel, endogenous pigments, fixation history, treatment, and mounting medium. | Autofluorescence by channel |
| Patchy or edge-biased staining | Bubbles, incomplete coverage, local drying, folds, detachment, illumination gradient, and focus. | Uneven-staining patterns |
| Good signal but poor morphology | Freezing artifacts, cryostat temperature, blade condition, section compression, fixation route, detergent strength, and retrieval severity. | Fixation decision guide |
Minimum experimental record
- Tissue identity, source, biological replicate, collection delay, and pre-freezing treatment
- Perfusion or immersion fixation before freezing, cryoprotection, embedding medium, orientation, and freezing method
- Block storage temperature, duration, thaw history, cryostat temperature, blade, and section thickness
- Slide type or coating, drying and storage history, and section-quality observations before staining
- Post-section fixation, permeabilization, or retrieval conditions with rationale
- Blocking, primary, and secondary antibody identifiers, lots, concentrations, dilutions, times, temperatures, and volumes
- Wash composition, count, duration, volume, agitation, and any section lifting
- Unstained, secondary-only, positive, negative, serial-section, and single-color controls as applicable
- Mounting medium, coverslip, curing and storage interval, microscope, objective, channels, exposure, gain, z-step, and processing
- Raw control images, uncropped representative fields, excluded sections, and reasons for exclusion
References and protocol sources
- Immunofluorescence protocol for frozen tissue (IF-F) Manufacturer protocol
Cell Signaling Technology
Charged slides, cryosection thickness, fixation, blocking, antibody incubation, washing, and mounting starting conditions.
- Tissue sample preparation guidance for immunostaining Manufacturer protocol
Thermo Fisher Scientific
OCT embedding, cryosection handling, coated slides, acetone fixation, and frozen-slide preparation.
- Overview of immunofluorescence techniques Technical guide
Cell Signaling Technology
Matching antibodies and protocols to biological material and sample processing.
- Frozen tissues with citrate antigen retrieval Manufacturer protocol
Cell Signaling Technology
Antigen retrieval as an optional antibody-specific branch for frozen sections.